[Mechanism of action of danazol, personal clinical experiences and guidelines for the treatment of benign breast diseases]

Der Gynäkologe · 1989 · vol. 22(4) , pp. 271–3 · PMID:2676763 · W2400749104
Review OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-10 ⓘ

This paper details the mechanism of action of danazol, presents personal clinical experiences, and provides guidelines for treating benign breast diseases.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Breast Neoplasms Danazol Fibrocystic Breast Disease Precancerous Conditions Pregnadienes Breast Neoplasms Danazol Female Fibrocystic Breast Disease Humans Precancerous Conditions Pregnadienes

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T11:08:07.918008+00:00
pubmed
last seen: 2026-10-08T21:17:08.544769+00:00
License: CC0 · commercial use OK